Evidence map›Paper›PMID 29040593›Full record

ArticleJournal of neuropathology and experimental neurology2017

Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice.

Nicolas Naudet, Emilie Antier, Damien Gaillard, Eric Morignat, Latifa Lakhdar, Thierry Baron, Anna Bencsik

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Enteric Nervous System Damage by Food Contaminants: A Pathway to Neurodegeneration?Comprehensive reviews in food science and food safety · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Environmental toxins in neurodegeneration - a narrative review.Neurological research and practice · 2025
    Review
  6. Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nicolas NaudetNeurodegenerative Disease Unit; PFEA Unit; and Epidemiology Unit, French Agency for Food, Environmental and Occupational Health & Safety (Anses) Laboratory of Lyon, Université de Lyon, Lyon, France.
Emilie AntierNeurodegenerative Disease Unit; PFEA Unit; and Epidemiology Unit, French Agency for Food, Environmental and Occupational Health & Safety (Anses) Laboratory of Lyon, Université de Lyon, Lyon, France.
Damien GaillardNeurodegenerative Disease Unit; PFEA Unit; and Epidemiology Unit, French Agency for Food, Environmental and Occupational Health & Safety (Anses) Laboratory of Lyon, Université de Lyon, Lyon, France.
Eric MorignatNeurodegenerative Disease Unit; PFEA Unit; and Epidemiology Unit, French Agency for Food, Environmental and Occupational Health & Safety (Anses) Laboratory of Lyon, Université de Lyon, Lyon, France.
Latifa LakhdarNeurodegenerative Disease Unit; PFEA Unit; and Epidemiology Unit, French Agency for Food, Environmental and Occupational Health & Safety (Anses) Laboratory of Lyon, Université de Lyon, Lyon, France.
Thierry BaronNeurodegenerative Disease Unit; PFEA Unit; and Epidemiology Unit, French Agency for Food, Environmental and Occupational Health & Safety (Anses) Laboratory of Lyon, Université de Lyon, Lyon, France.
Anna BencsikNeurodegenerative Disease Unit; PFEA Unit; and Epidemiology Unit, French Agency for Food, Environmental and Occupational Health & Safety (Anses) Laboratory of Lyon, Université de Lyon, Lyon, France.
Université Claude Bernard Lyon 1 · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The misfolded α-synuclein protein, phosphorylated at serine 129 (pSer129 α-syn), is the hallmark of Parkinson disease (PD). Detected also in the enteric nervous system (ENS), it supports the recent theory that PD could start in the gut, rather than the brain. In a previous study, using a transgenic mouse model of human synucleinopathies expressing the A53T mutant α-synuclein (TgM83), in which a neurodegenerative process associated with α-synuclein occurs spontaneously in the brain, we have shown earlier onset of pSer129 α-syn in the ENS. Here, we used this model to study the impact of paraquat (PQ) a neurotoxic herbicide incriminated in PD in agricultural workers) on the enteric pSer129 α-syn expression in young mice. Orally delivered in the drinking water at 10 mg/kg/day for 6-8 weeks, the impact of PQ was measured in a time-dependent manner on weight, locomotor abilities, pSer129 α-syn, and glial fibrillary acidic protein (GFAP) expression levels in the ENS. Remarkably, pSer129 α-syn was detected in ENS earlier under PQ oral exposure and enteric GFAP expression was also increased. These findings bring additional support to the theory that neurotoxic agents such as PQ initiate idiopathic PD after oral delivery.

Indexed as

Administration, Oralalpha-SynucleinAnimalsEnteric Nervous SystemFemaleGene ExpressionHerbicidesHumansMaleMiceMice, Inbred C57BLMice, TransgenicMutationParaquatPhosphorylationalpha-SynucleinHerbicidesParaquatA53TChronic oral exposureEnteric nervous systemParaquatParkinson diseaseα-Synuclein

Identifiers

PMID29040593
PMCPMC5939863
OpenAlexW2760839990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.